1. Academic Validation
  2. Application of the bicyclo[1.1.1]pentane motif as a nonclassical phenyl ring bioisostere in the design of a potent and orally active γ-secretase inhibitor

Application of the bicyclo[1.1.1]pentane motif as a nonclassical phenyl ring bioisostere in the design of a potent and orally active γ-secretase inhibitor

  • J Med Chem. 2012 Apr 12;55(7):3414-24. doi: 10.1021/jm300094u.
Antonia F Stepan 1 Chakrapani Subramanyam Ivan V Efremov Jason K Dutra Theresa J O'Sullivan Kenneth J DiRico W Scott McDonald Annie Won Peter H Dorff Charles E Nolan Stacey L Becker Leslie R Pustilnik David R Riddell Gregory W Kauffman Bethany L Kormos Liming Zhang Yasong Lu Steven H Capetta Michael E Green Kapil Karki Evelyn Sibley Kevin P Atchison Andrew J Hallgren Christine E Oborski Ashley E Robshaw Blossom Sneed Christopher J O'Donnell
Affiliations

Affiliation

  • 1 Pfizer Worldwide Research & Development, Eastern Point Road, Groton, Connecticut 06340, USA. [email protected]
Abstract

Replacement of the central, para-substituted fluorophenyl ring in the γ-secretase Inhibitor 1 (BMS-708,163) with the bicyclo[1.1.1]pentane motif led to the discovery of compound 3, an equipotent enzyme inhibitor with significant improvements in passive permeability and aqueous solubility. The modified biopharmaceutical properties of 3 translated into excellent oral absorption characteristics (~4-fold ↑ C(max) and AUC values relative to 1) in a mouse model of γ-secretase inhibition. In addition, SAR studies into Other fluorophenyl replacements indicate the intrinsic advantages of the bicyclo[1.1.1]pentane moiety over conventional phenyl ring replacements with respect to achieving an optimal balance of properties (e.g., γ-secretase inhibition, aqueous solubility/permeability, in vitro metabolic stability). Overall, this work enhances the scope of the [1.1.1]-bicycle beyond that of a mere "spacer" unit and presents a compelling case for its broader application as a phenyl group replacement in scenarios where the aromatic ring count impacts physicochemical parameters and overall drug-likeness.

Figures